.png){kind=icon}
返回
Systemic sclerosis: Recent insights
.png){kind=icon}
PRE
AI
DOI：10.1016/j.jbspin.2014.10.010.png)
.png){kind=icon}
原文求助.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Systemic sclerosis is an orphan connective tissue disease characterized by alterations of the microvasculature, disturbances of the immune system and massive deposition of collagen and other matrix substances in the skin and internal organs. A major achievement of the recent years has been the validation of new classification criteria, allowing earlier diagnosis and earlier treatment of systemic sclerosis, before irreversible fibrosis and organ damage appeared (window of opportunity). Raynaud's phenomenon is usually the first sign of the disease and is considered as the main sentinel sign for the identification of very early systemic sclerosis. Systemic sclerosis is clinically heterogeneous and disease course remains unpredictable. Its prognosis depends on cardiopulmonary involvement and recent studies aim to identify serum or genetic biomarkers predictive of severe organ involvement. Moreover, the prospective followup of large cohorts has provided and will offer critical material to identify strong prognostic factors. Whereas the outcomes of vascular manifestations of the disease has been recently improved due to targeted therapy, recent data have highlighted that mortality has not changed over the past 40 years. This reflects the absence of efficacy of current available drugs to counteract the fibrotic process. Nevertheless, several targeted immunity therapies, commonly with proven efficacy in other immune diseases, are about to be investigated in systemic sclerosis. Indeed, promising results in small and open studies have been reported. This article deals with recent insights into classification criteria, pathogenesis, organ involvements, outcome and current and possible future therapeutic options in systemic sclerosis. (C) 2014 Societe francaise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.
Keyword:
Systemic sclerosis
Treatment
Pathogenesis
Raynaud's phenomenon
Fibrosis
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
4.3
论文数:
4.2K
被引数:
4.8K
机构
引用论文
Chain conformation from the direct calculation of the Raman spectra of the liquid n-alkanes C12–C20
PREAI
分享收藏Endocardial and myocardial involvement in systemic sclerosis - is there a relevant inflammatory component?.png)
JOINT BONE SPINE
JOINT BONE SPINEIF4.3
PREAI
分享收藏Advanced oxidation protein products decrease expression of nephrin and podocin in podocytes via ROS-dependent activation of p38 MAPK高级氧化蛋白产物通过ROS依赖性激活p38 MAPK来降低足细胞中nephrin和podocin的表达。
PREAI
分享收藏Enhancing Thermal Conductivity of Polyvinylidene Fluoride Composites by Carbon Fiber: Length Effect of the FillerPolymers
OAAI
PolymersIF0
OAAI分享收藏Effects of the additives n-propylammonium or n-butylammonium iodide on the performance of perovskite solar cellsRSC Advances
OAAI
RSC AdvancesIF0
OAAI分享收藏
查看更多内容